DrugPatentWatch Database Preview
« Back to Dashboard
There are twenty-two drug master file entries for candesartan cilexetil; hydrochlorothiazide. Six suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for candesartan cilexetil; hydrochlorothiazide
Pharmacology for candesartan cilexetil; hydrochlorothiazide
|Drug Class||Angiotensin 2 Receptor Blocker |
|Mechanism of Action||Angiotensin 2 Receptor Antagonists |
|Physiological Effect||Increased Diuresis |
Synonyms for candesartan cilexetil; hydrochlorothiazide
|Candesartan cilexetil / hydrochlorothiazide|
|Candesartan cilexetil mixture with hydrochlorothiazide|
|Hydrochlorothiazide mixture with Candesartan cilexetil|
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.